Von Willebrand Factor Concentrate Administration for Acquired Von Willebrand Syndrome- Related Bleeding During Adult Extracorporeal Membrane Oxygenation
To review the use of Von Willebrand Factor (VWF) concentrate for treatment of acquired Von Willebrand syndrome (VWS)-related bleeding in adult extracorporeal membrane oxygenation (ECMO) patients and determine if it was associated with improved VWF laboratory parameters.
Source: Journal of Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Michael Mazzeffi, Allison Bathula, Ali Tabatabai, Jay Menaker, David Kaczorowski, Ronson Madathil, Samuel Galvagno, Chetan Pasrija, Raymond Rector, Kenichi Tanaka, Daniel Herr Tags: Original Article Source Type: research
More News: Anesthesia | Anesthesiology | Bleeding | Cardiology | Heart | Laboratory Medicine | Men | von Willebrand Disease